Downstream Processing Market Insights on Trends and Growth Forecast by 2032

Posted by Ganesh Shinde on May 30th, 2023

Between 2022 and 2032, the Downstream Processing Market Demand is expected to increase at an 11.3% CAGR, reaching a market value of US$ 72.3 billion by the end of 2032. The global Downstream Processing market is expected to be worth .0 billion in 2021 and US$ 24.9 billion by the end of 2022.

Downstream processing produces antibiotics, antibodies, hormones, and vaccines, as well as industrial enzymes. Downstream processing is the purification and recovery of biosynthetic products derived from natural sources such as animal and plant tissues.

The Downstream Processing business is driven by expanding biopharmaceutical demand and rising R&D spending on their development. However, the high cost of Downstream Processing equipment, as well as a scarcity of skilled workers, are hindering industry expansion.

The report has also included the profiles of some of the leading companies in the Downstream Processing market like Sartorius Aktiengesellschaft, Repligen Corporation, Merck & Co Inc., Thermo Fisher Scientific, Inc., Eppendorf AG, General Electric Company, Corning Incorporated, 3M Company, Lonza Group Ltd. and Danaher Corporation.

Get More Details@ https://www.futuremarketinsights.com/reports/downstream-processing-market

Market Taxonomy

Product Type:

• Chromatography Column and Resins
• Membrane Adsorbers
• Single-use Products
• Consumables and Accessories

End Users:

• Biopharmaceutical Manufacturers
• Contract Manufacturing Organizations (CMOs)

Applications:

• Monoclonal Antibody Production
• Vaccine Production
• Insulin Production
• Immunoglobulin Production
• Erythropoietin Production
• Other Application

By Technique:

• Separation
• Concentration
• Purification